Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin

被引：0
|
作者：
Aya Takahashi
Yoshiyasu Fukusumi
Mihoko Yamazaki
Mutsumi Kayaba
Yukina Kitazawa
Masayuki Tomita
Hiroshi Kawachi
机构：
[1] Niigata University Graduate School of Medical and Dental Sciences,Department of Cell Biology, Institute of Nephrology
来源：
Journal of Nephrology | 2014年 / 27卷
关键词：
ARB; Podocyte; Slit diaphragm; NEPH1; Nephrin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 634
页数：7
相关论文
共 50 条
  • [1] Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin
    Takahashi, Aya
    Fukusumi, Yoshiyasu
    Yamazaki, Mihoko
    Kayaba, Mutsumi
    Kitazawa, Yukina
    Tomita, Masayuki
    Kawachi, Hiroshi
    JOURNAL OF NEPHROLOGY, 2014, 27 (06) : 627 - 634
  • [2] Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN
    Donoviel, DB
    Freed, DD
    Vogel, H
    Potter, DG
    Hawkins, E
    Barrish, JP
    Mathur, BN
    Turner, CA
    Geske, R
    Montgomery, CA
    Starbuck, M
    Brandt, M
    Gupta, A
    Ramirez-Solis, R
    Zambrowicz, BP
    Powell, DR
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (14) : 4829 - 4836
  • [3] Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity
    Padi, SSV
    Chopra, K
    PHARMACOLOGICAL RESEARCH, 2002, 45 (05) : 413 - 420
  • [4] Angiotensin II receptor antagonist prevents the reduction of nephrin expression and attenuates proteinuria in anti-nephrin monoclonal antibody 5-1-6 induced nephropathy.
    Suzuki, K
    Koike, H
    Han, GD
    Nakatsue, T
    Shimizu, F
    Kawachi, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 160A - 160A
  • [5] Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
    Hulkko, Jenny
    Patrakka, Jaakko
    Lal, Mark
    Tryggvason, Karl
    Hultenby, Kjell
    Wernerson, Annika
    NEPHRON EXTRA, 2014, 4 (03): : 146 - 154
  • [6] Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
    Benicky, Julius
    Sanchez-Lemus, Enrique
    Honda, Masaru
    Pang, Tao
    Orecna, Martina
    Wang, Juan
    Leng, Yan
    Chuang, De-Maw
    Saavedra, Juan M.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (04) : 857 - 870
  • [7] Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
    Julius Benicky
    Enrique Sánchez-Lemus
    Masaru Honda
    Tao Pang
    Martina Orecna
    Juan Wang
    Yan Leng
    De-Maw Chuang
    Juan M Saavedra
    Neuropsychopharmacology, 2011, 36 : 857 - 870
  • [8] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    KIDNEY INTERNATIONAL, 2000, 57 (02) : 601 - 606
  • [9] Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy
    Lutz, J.
    Risch, K.
    Liu, S.
    Antus, B.
    Schmaderer, C.
    Roos, M.
    Ouyang, N.
    Lehmann, M.
    Heemann, U.
    KIDNEY INTERNATIONAL, 2006, 70 (06) : 1080 - 1088
  • [10] Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency
    Suga, S
    Mazzali, M
    Ray, PE
    Kang, DH
    Johnson, RJ
    KIDNEY INTERNATIONAL, 2002, 61 (03) : 951 - 958
12345